Uso clínico y beneficios no anticonceptivos de dispositivo intrauterino hormonal (diu-lng), en mujeres en edad fértil

Abstract

Introduction: New contraceptive devices including the hormonal-releasing intrauterine device, are now available for contraception. Through the gradual release of contraceptive hormones, this device effectively prevents fertilization. However, additional systemic effects have been observed, including benefits in controlling various pathologies such as dysmenorrhea, metrorrhagia, endometrial cancer, endometriosis, and endometrial hyperplasia. Understanding these benefits presents new therapeutic options for those suffering from these conditions. Methodology: This study consists of a literature review on the clinical use and non-contraceptive advantages of hormonal intrauterine devices in women of childbearing age. Relevant data were extracted from scientific databases such as PubMed, SciELO, Cochrane Library, and ScienceDirect. Results: Sixty-one articles were reviewed, summarizing the principal non-contraceptive benefits of hormonal intrauterine devices in fertile women. It became apparent that these devices offer various non-contraceptive benefits. The LNG-IUD (Levonorgestrel Intrauterine Device) can be considered a first line of treatment for menorrhagia, dysmenorrhea, endometriosis, and adenomyosis. Additionally, it is noteworthy that adverse effects are minimal compared to the advantages. Conclusions: Using hormonal-releasing intrauterine devices has advantageous effects in managing pain associated with dysmenorrhea and achieving complete remission of endometrial cancer. It is considered a safe method, and its adverse events are infrequent and with low morbidity and mortality. Although the protocols have not been established as a first line of management for specific pathologies, the evidence has shown favorable outcomes.